Last 12 months
Inside the activity.
0 purchase rows · 9 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2022 Filed Jun 17, 2022 20:41 UTC |
Moos James RobertGroup President
|
Tax withholdingCommon Stock | 611 | $97.91 | $59,823.01 |
DisclosureSEC source: 0001803941-22-000004 · wf-form4_165549849999190.xml · nonDerivative · entry 2 Moos James Robert · CIK 0001803941 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,907 F1 · kind: This transaction was executed pursuant to a trading plan entered into by the reporting person on March 2, 2022, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · kind: Represents shares of common stock withheld by the issuer in connection with the option exercise to cover the exercise price and associated fees. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:41 UTC |
Moos James RobertGroup President
|
Exercise / conversionCommon Stock | 1,127 | $33.82 | $38,112.55 |
DisclosureSEC source: 0001803941-22-000004 · wf-form4_165549849999190.xml · nonDerivative · entry 1 Moos James Robert · CIK 0001803941 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was executed pursuant to a trading plan entered into by the reporting person on March 2, 2022, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 26, 2022 Filed May 31, 2022 21:44 UTC |
KRAEMER HARRY M JANSEN JRDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,523 | $0.00 Strike: $31.62 | $0.00 |
DisclosureSEC source: 0001628280-22-015789 · wf-form4_165403344523390.xml · derivative · entry 5 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,523 shares Expires 2022-06-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: This stock option was previously reported as a stock option grant for 7,777 shares of common stock at an exercise price of $42.79 per share. The number of options and the exercise price were subsequentlyadjusted to reflect a special dividend declared by the issuer in August 2016. F2 · derivative.underlying_shares: This stock option was previously reported as a stock option grant for 7,777 shares of common stock at an exercise price of $42.79 per share. The number of options and the exercise price were subsequentlyadjusted to reflect a special dividend declared by the issuer in August 2016. Read SEC document |
| May 26, 2022 Filed May 31, 2022 21:44 UTC |
KRAEMER HARRY M JANSEN JRDirector
|
SaleCommon Stock | 7,274 | $103.18 | $750,531.32 |
DisclosureSEC source: 0001628280-22-015789 · wf-form4_165403344523390.xml · nonDerivative · entry 3 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,277 Read SEC document |
| May 26, 2022 Filed May 31, 2022 21:44 UTC |
KRAEMER HARRY M JANSEN JRDirector
|
Tax withholdingCommon Stock | 3,249 | $102.39 | $332,665.11 |
DisclosureSEC source: 0001628280-22-015789 · wf-form4_165403344523390.xml · nonDerivative · entry 2 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,551 F1 · kind: Represents shares of common stock withheld by the issuer in connection with the option exercise to cover the exercise price and associated fees. Read SEC document |
| May 26, 2022 Filed May 31, 2022 21:44 UTC |
KRAEMER HARRY M JANSEN JRDirector
|
Exercise / conversionCommon Stock | 10,523 | $31.62 | $332,766.72 |
DisclosureSEC source: 0001628280-22-015789 · wf-form4_165403344523390.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2022 Filed May 10, 2022 21:00 UTC |
May Gary StephenDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,523 | $0.00 Strike: $31.62 | $0.00 |
DisclosureSEC source: 0001628280-22-013645 · wf-form4_165221644207797.xml · derivative · entry 6 May Gary Stephen · CIK 0001635110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,523 shares Expires 2022-06-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: This stock option was previously reported as a stock option grant for 7,777 shares of common stock at an exercise price of $42.79 per share. The number of options and the exercise price were subsequently adjusted to reflect a special dividend declared by the issuer in August 2016. F4 · derivative.underlying_shares: This stock option was previously reported as a stock option grant for 7,777 shares of common stock at an exercise price of $42.79 per share. The number of options and the exercise price were subsequently adjusted to reflect a special dividend declared by the issuer in August 2016. Read SEC document |
| May 09, 2022 Filed May 10, 2022 21:00 UTC |
May Gary StephenDirector
|
SaleCommon Stock | 7,299 | $102.35 | $747,041.70 |
DisclosureSEC source: 0001628280-22-013645 · wf-form4_165221644207797.xml · nonDerivative · entry 4 May Gary Stephen · CIK 0001635110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,778 F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions from $102.23 to $102.65 inclusive. The reporting person undertakes to providing to Leidos Holdings, Inc., any security holder of Leidos Holdings, Inc., or the staff of the Securities Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the aforementioned range. Read SEC document |
| May 09, 2022 Filed May 10, 2022 21:00 UTC |
May Gary StephenDirector
|
Tax withholdingCommon Stock | 3,224 | $103.21 | $332,749.04 |
DisclosureSEC source: 0001628280-22-013645 · wf-form4_165221644207797.xml · nonDerivative · entry 3 May Gary Stephen · CIK 0001635110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,077 F1 · kind: Represents shares of common stock withheld by the issuer in connection with the option exercise to cover the exercise price and associated fees. Read SEC document |
| May 09, 2022 Filed May 10, 2022 21:00 UTC |
May Gary StephenDirector
|
Exercise / conversionCommon Stock | 10,523 | $31.62 | $332,766.72 |
DisclosureSEC source: 0001628280-22-013645 · wf-form4_165221644207797.xml · nonDerivative · entry 2 May Gary Stephen · CIK 0001635110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,301 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2022 Filed May 10, 2022 21:02 UTC |
KRAEMER HARRY M JANSEN JRDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,784 | $0.00 Strike: $104.06 | $0.00 |
DisclosureSEC source: 0001628280-22-013646 · wf-form4_165221655395474.xml · derivative · entry 3 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,784 Underlying: Common Stock · 1,784 shares Expires 2029-05-05 F1 · derivative.exercise_date: The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded. Read SEC document |
| May 06, 2022 Filed May 10, 2022 21:02 UTC |
KRAEMER HARRY M JANSEN JRDirector
|
GrantCommon Stock | 1,106 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-013646 · wf-form4_165221655395474.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 118,531.2437 Read SEC document |
| May 06, 2022 Filed May 10, 2022 21:15 UTC |
SHAPARD ROBERT SDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,784 | $0.00 Strike: $104.06 | $0.00 |
DisclosureSEC source: 0001628280-22-013664 · wf-form4_165221732496316.xml · derivative · entry 2 SHAPARD ROBERT S · CIK 0001121300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,784 Underlying: Common Stock · 1,784 shares Expires 2029-05-05 F1 · derivative.exercise_date: The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded. Read SEC document |
| May 06, 2022 Filed May 10, 2022 21:15 UTC |
SHAPARD ROBERT SDirector
|
GrantCommon Stock | 1,106 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-013664 · wf-form4_165221732496316.xml · nonDerivative · entry 1 SHAPARD ROBERT S · CIK 0001121300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,615.08 Read SEC document |
| May 06, 2022 Filed May 10, 2022 21:07 UTC |
Shanahan Patrick MDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,156 | $0.00 Strike: $104.06 | $0.00 |
DisclosureSEC source: 0001628280-22-013654 · wf-form4_165221684475158.xml · derivative · entry 2 Shanahan Patrick M · CIK 0001670946 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,156 Underlying: Common Stock · 2,156 shares Expires 2029-05-05 F1 · derivative.exercise_date: The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded. Read SEC document |
| May 06, 2022 Filed May 10, 2022 21:07 UTC |
Shanahan Patrick MDirector
|
GrantCommon Stock | 1,336 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-013654 · wf-form4_165221684475158.xml · nonDerivative · entry 1 Shanahan Patrick M · CIK 0001670946 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,336 Read SEC document |
| May 06, 2022 Filed May 10, 2022 17:31 UTC |
JOHN MIRIAM EDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,784 | $0.00 Strike: $104.06 | $0.00 |
DisclosureSEC source: 0001628280-22-013684 · wf-form4_165221823711843.xml · derivative · entry 3 JOHN MIRIAM E · CIK 0001401703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,784 Underlying: Common Stock · 1,784 shares Expires 2029-05-05 F1 · derivative.exercise_date: The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded. Read SEC document |
| May 06, 2022 Filed May 10, 2022 17:31 UTC |
JOHN MIRIAM EDirector
|
GrantCommon Stock | 1,106 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-013684 · wf-form4_165221823711843.xml · nonDerivative · entry 1 JOHN MIRIAM E · CIK 0001401703 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 77,593.746 Read SEC document |
| May 06, 2022 Filed May 10, 2022 18:01 UTC |
MOHAPATRA SURYA NDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,784 | $0.00 Strike: $104.06 | $0.00 |
DisclosureSEC source: 0001628280-22-013704 · wf-form4_165221980970369.xml · derivative · entry 2 MOHAPATRA SURYA N · CIK 0001222671 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,784 Underlying: Common Stock · 1,784 shares Expires 2029-05-05 F1 · derivative.exercise_date: The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded. Read SEC document |
| May 06, 2022 Filed May 10, 2022 18:01 UTC |
MOHAPATRA SURYA NDirector
|
GrantCommon Stock | 1,106 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-013704 · wf-form4_165221980970369.xml · nonDerivative · entry 1 MOHAPATRA SURYA N · CIK 0001222671 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,515 Read SEC document |
| May 06, 2022 Filed May 10, 2022 20:53 UTC |
STALNECKER SUSAN MDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,784 | $0.00 Strike: $104.06 | $0.00 |
DisclosureSEC source: 0001628280-22-013641 · wf-form4_165221594677674.xml · derivative · entry 2 STALNECKER SUSAN M · CIK 0001221375 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,784 Underlying: Common Stock · 1,784 shares Expires 2029-05-05 F1 · derivative.exercise_date: The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded. Read SEC document |
| May 06, 2022 Filed May 10, 2022 20:53 UTC |
STALNECKER SUSAN MDirector
|
GrantCommon Stock | 1,106 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-013641 · wf-form4_165221594677674.xml · nonDerivative · entry 1 STALNECKER SUSAN M · CIK 0001221375 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,615 Read SEC document |
| May 06, 2022 Filed May 10, 2022 21:45 UTC |
Geer Noel BDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,784 | $0.00 Strike: $104.06 | $0.00 |
DisclosureSEC source: 0001628280-22-013692 · wf-form4_165221912139397.xml · derivative · entry 3 WILLIAMS NOEL B · CIK 0001216858 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,784 Underlying: Common Stock · 1,784 shares Expires 2029-05-05 F1 · derivative.exercise_date: The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded. Read SEC document |
| May 06, 2022 Filed May 10, 2022 21:45 UTC |
Geer Noel BDirector
|
GrantCommon Stock | 1,106 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-013692 · wf-form4_165221912139397.xml · nonDerivative · entry 1 WILLIAMS NOEL B · CIK 0001216858 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,369.8435 Read SEC document |
| May 06, 2022 Filed May 10, 2022 21:52 UTC |
Dahlberg Gregory RDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,784 | $0.00 Strike: $104.06 | $0.00 |
DisclosureSEC source: 0001628280-22-013700 · wf-form4_165221955312101.xml · derivative · entry 2 Dahlberg Gregory R · CIK 0001682434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,784 Underlying: Common Stock · 1,784 shares Expires 2029-05-05 F1 · derivative.exercise_date: The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded. Read SEC document |
| May 06, 2022 Filed May 10, 2022 21:52 UTC |
Dahlberg Gregory RDirector
|
GrantCommon Stock | 1,106 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-013700 · wf-form4_165221955312101.xml · nonDerivative · entry 1 Dahlberg Gregory R · CIK 0001682434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,615 Read SEC document |
| May 06, 2022 Filed May 10, 2022 22:05 UTC |
Cook Stephen AllenGroup President
|
GrantStock Option (Right to Buy) · Derivative | 3,315 | $0.00 Strike: $104.06 | $0.00 |
DisclosureSEC source: 0001628280-22-013713 · wf-form4_165222033081822.xml · derivative · entry 1 Cook Stephen Allen · CIK 0001927795 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,315 Underlying: Common Stock · 3,315 shares Expires 2029-05-05 F1 · derivative.exercise_date: The option shall vest in four equal annual installments beginning on May 6, 2023. Read SEC document |
| May 06, 2022 Filed May 10, 2022 21:37 UTC |
Kovarik Robert C JRDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,784 | $0.00 Strike: $104.06 | $0.00 |
DisclosureSEC source: 0001628280-22-013688 · wf-form4_165221862337646.xml · derivative · entry 2 Kovarik Robert C JR · CIK 0001512157 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,784 Underlying: Common Stock · 1,784 shares Expires 2029-05-05 F1 · derivative.exercise_date: The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded. Read SEC document |
| May 06, 2022 Filed May 10, 2022 21:37 UTC |
Kovarik Robert C JRDirector
|
GrantCommon Stock | 1,106 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-013688 · wf-form4_165221862337646.xml · nonDerivative · entry 1 Kovarik Robert C JR · CIK 0001512157 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,028 Read SEC document |
| May 06, 2022 Filed May 10, 2022 21:25 UTC |
Fubini David GDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,784 | $0.00 Strike: $104.06 | $0.00 |
DisclosureSEC source: 0001628280-22-013676 · wf-form4_165221790752550.xml · derivative · entry 2 Fubini David G · CIK 0001574002 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,784 Underlying: Common Stock · 1,784 shares Expires 2029-05-05 F1 · derivative.exercise_date: The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded. Read SEC document |
| May 06, 2022 Filed May 10, 2022 21:25 UTC |
Fubini David GDirector
|
GrantCommon Stock | 1,106 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-013676 · wf-form4_165221790752550.xml · nonDerivative · entry 1 Fubini David G · CIK 0001574002 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,837.8435 Read SEC document |
| May 06, 2022 Filed May 10, 2022 21:00 UTC |
May Gary StephenDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,784 | $0.00 Strike: $104.06 | $0.00 |
DisclosureSEC source: 0001628280-22-013645 · wf-form4_165221644207797.xml · derivative · entry 5 May Gary Stephen · CIK 0001635110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,784 Underlying: Common Stock · 1,784 shares Expires 2029-05-05 F3 · derivative.exercise_date: The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded. Read SEC document |
| May 06, 2022 Filed May 10, 2022 21:00 UTC |
May Gary StephenDirector
|
GrantCommon Stock | 1,106 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-013645 · wf-form4_165221644207797.xml · nonDerivative · entry 1 May Gary Stephen · CIK 0001635110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,778 Read SEC document |
| April 29, 2022 Filed May 2, 2022 20:31 UTC |
KRAEMER HARRY M JANSEN JRDirector
|
GrantCommon Stock | 14.3176 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-011740 · wf-form4_165152343677382.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 117,425.2437 F1 · shares: Dividend equivalent rights. Read SEC document |
| April 29, 2022 Filed May 2, 2022 16:36 UTC |
JOHN MIRIAM EDirector
|
GrantCommon Stock | 14.3176 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-011742 · wf-form4_165152355516074.xml · nonDerivative · entry 1 JOHN MIRIAM E · CIK 0001401703 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 76,487.746 F1 · shares: Dividend equivalent rights. Read SEC document |
| April 08, 2022 Filed Apr 8, 2022 16:14 UTC |
JOHN MIRIAM EDirector
|
GrantCommon Stock | 323.8642 | $108.07 | $35,000.00 |
DisclosureSEC source: 0001628280-22-008819 · wf-form4_164944883703904.xml · nonDerivative · entry 1 JOHN MIRIAM E · CIK 0001401703 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 76,473.4284 F1 · shares: Represents retainer fees for services on the Company's Board of Directors and any committees thereof that the reporting person elected to defer into the Company's Key Executive Stock Deferral Plan. The amount reported on Column 4 represents the quotient of (A) such retainer fees divided by (B) the Company's closing stock price the day prior to the date awarded. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 19:16 UTC |
KRONE ROGER ADirector · CEO
|
GrantCommon Stock | 717.8998 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-008298 · wf-form4_164911415401642.xml · nonDerivative · entry 1 KRONE ROGER A · CIK 0001013082 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 235,222.0732 F1 · shares: Dividend equivalent rights. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 23:13 UTC |
KRAEMER HARRY M JANSEN JRDirector
|
GrantCommon Stock | 393.6188 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-008295 · wf-form4_164911398734848.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 117,410.9261 F1 · shares: Dividend equivalent rights. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 19:11 UTC |
HOWE JERALD S JREVP, General Counsel
|
GrantCommon Stock | 40.7083 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-008292 · wf-form4_164911386604076.xml · nonDerivative · entry 1 HOWE JERALD S JR · CIK 0001176529 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 17,833.6945 F1 · shares: Dividend equivalent rights. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 19:26 UTC |
JOHN MIRIAM EDirector
|
GrantCommon Stock | 248.6349 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-008310 · wf-form4_164911477645800.xml · nonDerivative · entry 1 JOHN MIRIAM E · CIK 0001401703 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 76,149.5642 F1 · shares: Dividend equivalent rights. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 23:23 UTC |
Moos James RobertGroup President
|
GrantCommon Stock | 18.2322 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-008307 · wf-form4_164911460207897.xml · nonDerivative · entry 1 Moos James Robert · CIK 0001803941 · Group President 10b5-1 filing: Not disclosed Ownership: Indirect · by Key Executive Stock Deferral Plan Disclosed balance after: 9,673.6358 F1 · shares: Dividend equivalent rights. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 23:21 UTC |
Cage Christopher RChief Financial Officer
|
GrantCommon Stock | 74.8372 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-008304 · wf-form4_164911445049081.xml · nonDerivative · entry 1 Cage Christopher R · CIK 0001779866 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 22,613.3483 F1 · shares: Dividend equivalent rights. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 23:18 UTC |
Opiekun Deborah D.Chief Business Development
|
GrantCommon Stock | 8.8555 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-008301 · wf-form4_164911430950922.xml · nonDerivative · entry 1 Opiekun Deborah D. · CIK 0001891453 · Chief Business Development 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 2,675.8264 F1 · shares: Dividend equivalent rights. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 23:07 UTC |
Stevens Roy EGroup President
|
GrantCommon Stock | 5.7378 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-008289 · wf-form4_164911364533562.xml · nonDerivative · entry 1 Stevens Roy E · CIK 0001755314 · Group President 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 1,708.706 F1 · shares: Dividend equivalent rights. Read SEC document |
| March 23, 2022 Filed Mar 23, 2022 17:19 UTC |
KRONE ROGER ADirector · CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 69,392 | $0.00 Strike: $31.55 | $0.00 |
DisclosureSEC source: 0001628280-22-007054 · wf-form4_164807037006997.xml · derivative · entry 12 KRONE ROGER A · CIK 0001013082 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 69,392 shares Expires 2022-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was executed pursuant to a trading plan entered into by the reporting person on February 18, 2022, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F6 · shares: This stock option was previously reported as a stock option grant for 102,565 shares of common stock at an exercise price of $42.69 per share. The number of options and the exercise price were subsequently adjusted to reflect a special dividend declared by the issuer in August 2016. F6 · derivative.underlying_shares: This stock option was previously reported as a stock option grant for 102,565 shares of common stock at an exercise price of $42.69 per share. The number of options and the exercise price were subsequently adjusted to reflect a special dividend declared by the issuer in August 2016. Read SEC document |
| March 23, 2022 Filed Mar 23, 2022 17:19 UTC |
KRONE ROGER ADirector · CEO
|
SaleCommon Stock | 100 | $106.77 | $10,677.00 |
DisclosureSEC source: 0001628280-22-007054 · wf-form4_164807037006997.xml · nonDerivative · entry 8 KRONE ROGER A · CIK 0001013082 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,941.1753 F1 · kind: This transaction was executed pursuant to a trading plan entered into by the reporting person on February 18, 2022, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 23, 2022 Filed Mar 23, 2022 17:19 UTC |
KRONE ROGER ADirector · CEO
|
SaleCommon Stock | 25,331 | $106.16 | $2,689,080.70 |
DisclosureSEC source: 0001628280-22-007054 · wf-form4_164807037006997.xml · nonDerivative · entry 7 KRONE ROGER A · CIK 0001013082 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,041.1753 F1 · kind: This transaction was executed pursuant to a trading plan entered into by the reporting person on February 18, 2022, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices from $105.70 to $106.64 inclusive. The reporting person undertakes to providing to Leidos Holdings, Inc., any security holder of Leidos Holdings, Inc., or the staff of the Securities Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the aforementioned range. Read SEC document |
| March 23, 2022 Filed Mar 23, 2022 17:19 UTC |
KRONE ROGER ADirector · CEO
|
Tax withholdingCommon Stock | 43,961 | $106.42 | $4,678,329.62 |
DisclosureSEC source: 0001628280-22-007054 · wf-form4_164807037006997.xml · nonDerivative · entry 6 KRONE ROGER A · CIK 0001013082 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,372.1753 F1 · kind: This transaction was executed pursuant to a trading plan entered into by the reporting person on February 18, 2022, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · kind: Represents shares of common stock withheld by the issuer in connection with the option exercise to cover the exercise price and associated fees. Read SEC document |
| March 23, 2022 Filed Mar 23, 2022 17:19 UTC |
KRONE ROGER ADirector · CEO
|
Exercise / conversionCommon Stock | 69,392 | $31.55 | $2,189,241.27 |
DisclosureSEC source: 0001628280-22-007054 · wf-form4_164807037006997.xml · nonDerivative · entry 5 KRONE ROGER A · CIK 0001013082 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,333.1753 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was executed pursuant to a trading plan entered into by the reporting person on February 18, 2022, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 17:19 UTC |
KRONE ROGER ADirector · CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 69,392 | $0.00 Strike: $31.55 | $0.00 |
DisclosureSEC source: 0001628280-22-007054 · wf-form4_164807037006997.xml · derivative · entry 11 KRONE ROGER A · CIK 0001013082 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,392 Underlying: Common Stock · 69,392 shares Expires 2022-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was executed pursuant to a trading plan entered into by the reporting person on February 18, 2022, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F6 · shares: This stock option was previously reported as a stock option grant for 102,565 shares of common stock at an exercise price of $42.69 per share. The number of options and the exercise price were subsequently adjusted to reflect a special dividend declared by the issuer in August 2016. F6 · derivative.underlying_shares: This stock option was previously reported as a stock option grant for 102,565 shares of common stock at an exercise price of $42.69 per share. The number of options and the exercise price were subsequently adjusted to reflect a special dividend declared by the issuer in August 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.